PMDA Japan
E821690
PMDA Japan is Japan’s national regulatory authority responsible for evaluating and overseeing the safety, efficacy, and quality of pharmaceuticals and medical devices.
All labels observed (1)
| Label | Occurrences |
|---|---|
| PMDA Japan canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T9806891 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: PMDA Japan Context triple: [Chugai Pharmaceutical, regulatoryRegion, PMDA Japan]
-
A.
National Land Agency of Japan
The National Land Agency of Japan was a former government body responsible for national land-use planning, development, and coordination before its functions were absorbed into the Ministry of Land, Infrastructure, Transport and Tourism.
-
B.
Japan Implementing Organization
The Japan Implementing Organization is a Japanese research body responsible for managing and conducting that country's scientific ocean drilling activities within the Integrated Ocean Drilling Program.
-
C.
Geospatial Information Authority of Japan
The Geospatial Information Authority of Japan is the national agency responsible for surveying, mapping, and managing geospatial and geographic information across Japan.
-
D.
Water and Disaster Management Bureau of Japan
The Water and Disaster Management Bureau of Japan is a governmental body responsible for planning and implementing policies on water resources, flood control, and disaster prevention across the country.
-
E.
Maritime Bureau of Japan
The Maritime Bureau of Japan is a governmental body responsible for formulating and implementing Japan’s maritime policies, including shipping administration, maritime safety, and port and coastal management.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: PMDA Japan Target entity description: PMDA Japan is Japan’s national regulatory authority responsible for evaluating and overseeing the safety, efficacy, and quality of pharmaceuticals and medical devices.
-
A.
National Land Agency of Japan
The National Land Agency of Japan was a former government body responsible for national land-use planning, development, and coordination before its functions were absorbed into the Ministry of Land, Infrastructure, Transport and Tourism.
-
B.
Japan Implementing Organization
The Japan Implementing Organization is a Japanese research body responsible for managing and conducting that country's scientific ocean drilling activities within the Integrated Ocean Drilling Program.
-
C.
Geospatial Information Authority of Japan
The Geospatial Information Authority of Japan is the national agency responsible for surveying, mapping, and managing geospatial and geographic information across Japan.
-
D.
Water and Disaster Management Bureau of Japan
The Water and Disaster Management Bureau of Japan is a governmental body responsible for planning and implementing policies on water resources, flood control, and disaster prevention across the country.
-
E.
Maritime Bureau of Japan
The Maritime Bureau of Japan is a governmental body responsible for formulating and implementing Japan’s maritime policies, including shipping administration, maritime safety, and port and coastal management.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
government agency
ⓘ
pharmaceutical regulatory agency ⓘ regulatory authority ⓘ |
| abbreviation | PMDA NERFINISHED ⓘ |
| collaboratesWith | Ministry of Health, Labour and Welfare of Japan NERFINISHED ⓘ |
| country | Japan ⓘ |
| hasRole |
providing relief services for adverse drug reactions
ⓘ
providing relief services for infections caused by biological products ⓘ regulatory science promotion ⓘ risk management of medical products ⓘ |
| headquartersLocation |
Japan
ⓘ
Tokyo ⓘ |
| jurisdiction | Japan ⓘ |
| memberOf |
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
NERFINISHED
ⓘ
International Medical Device Regulators Forum NERFINISHED ⓘ |
| officialName | Pharmaceuticals and Medical Devices Agency NERFINISHED ⓘ |
| oversees |
efficacy of medical devices
ⓘ
efficacy of pharmaceuticals ⓘ quality of medical devices ⓘ quality of pharmaceuticals ⓘ safety of medical devices ⓘ safety of pharmaceuticals ⓘ |
| regulates |
biologics
ⓘ
in vitro diagnostics ⓘ medical devices ⓘ over-the-counter drugs ⓘ prescription drugs ⓘ regenerative medicine products ⓘ vaccines ⓘ |
| responsibleFor |
GCP inspection
ⓘ
GLP inspection ⓘ GMP inspection ⓘ clinical trial review ⓘ drug safety evaluation ⓘ marketing authorization review ⓘ medical device regulation ⓘ medical device safety monitoring ⓘ pharmaceutical regulation ⓘ pharmacovigilance ⓘ post-marketing safety surveillance ⓘ regulation of regenerative medical products ⓘ |
| sector |
healthcare regulation
ⓘ
public health ⓘ |
| worksWith |
European Medicines Agency
NERFINISHED
ⓘ
U.S. Food and Drug Administration NERFINISHED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: PMDA Japan Description of subject: PMDA Japan is Japan’s national regulatory authority responsible for evaluating and overseeing the safety, efficacy, and quality of pharmaceuticals and medical devices.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.